Meghara Walsh
- Pulmonary and Respiratory Medicine top 5%
- Molecular Biology
- Oncology top 5%
- Cancer Research top 5%
- Surgery top 10%
- Co-authors
- Toni K. ChoueiriM. Dror MichaelsonDaniel J. GeorgeJoel PicusSusan HalabiShaker R. DakhilMichael J. MorrisOlwen Hahn
- Topics
- Renal cell carcinoma treatment (16 papers)Renal and related cancers (10 papers)Pancreatic and Hepatic Oncology Research (5 papers)
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Meghara Walsh
20 papers receiving 1.1k citations
Hit Papers
Peers
Comparison fields: 5 of 56
- Pulmonary and Respiratory Medicine 833
- Molecular Biology 515
- Oncology 499
- Cancer Research 379
- Surgery 290
Countries citing papers authored by Meghara Walsh
This map shows the geographic impact of Meghara Walsh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meghara Walsh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meghara Walsh more than expected).
Fields of papers citing papers by Meghara Walsh
This network shows the impact of papers produced by Meghara Walsh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meghara Walsh. The network helps show where Meghara Walsh may publish in the future.
Co-authorship network of co-authors of Meghara Walsh
This figure shows the co-authorship network connecting the top 25 collaborators of Meghara Walsh. A scholar is included among the top collaborators of Meghara Walsh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meghara Walsh. Meghara Walsh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 12 | |
| 3 | 20 | |
| 4 | 19 | |
| 5 | 26 | |
| 6 | 2 | |
| 7 | 267 | |
| 8 | 7 | |
| 9 | 22 | |
| 10 | Cabozantinib Versus Sunitinib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma of Poor or Intermediate Risk: The Alliance A031203 CABOSUN Trialbreakdown → | 507 |
| 11 | 12 | |
| 12 | 2 | |
| 13 | 7 | |
| 14 | 13 | |
| 15 | 13 | |
| 16 | 2 | |
| 17 | 9 | |
| 18 | 184 | |
| 19 | 5 | |
| 20 | 1 |
About Meghara Walsh
Meghara Walsh is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research, having authored 20 papers that have together received 1.1k indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (16 papers), Renal and related cancers (10 papers) and Pancreatic and Hepatic Oncology Research (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (833 citations), Cancer Research (379 citations) and Oncology (499 citations). Meghara Walsh has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Toni K. Choueiri, M. Dror Michaelson, Daniel J. George, Joel Picus, Susan Halabi, Shaker R. Dakhil, Michael J. Morris, Olwen Hahn, Eric J. Small and Darren R. Feldman. Their work appears in journals such as Journal of Clinical Oncology, Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.